Morgan Stanley Maintains Overweight on NOV, Raises Price Target to $24
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Elizabeth Porter has maintained an Overweight rating on NOV (NYSE:NOV) and raised the price target from $22 to $24.
July 31, 2023 | 1:52 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained an Overweight rating on NOV and raised the price target from $22 to $24. This could potentially lead to an increase in the stock's price.
The Overweight rating indicates that Morgan Stanley believes NOV's stock will outperform the average return of the stocks the analyst compares it with. The increase in price target from $22 to $24 suggests that the analyst sees potential for the stock's price to increase. This could lead to a positive impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100